Drug factory · FDA FEI 3002806334

Ajinomoto Co., Inc.

1730 Oazahinaga, Yokkaichi, Japan

Japan: 1

Problems found, fixed voluntarily at FDA's last inspection, Nov 14, 2025.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

3 drug inspections on record since 2011: 0 with no problems, 3 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
Tipiracil and TrifluridineMakes the active ingredient and tests it Taiho Pharmaceutical Co., Ltd. 64842-1020, 64842-1025
ViltolarsenMakes the active ingredient NS Pharma, Inc. 73292-011

FDA inspection history

EndedResultProgramProblems noted
Nov 14, 2025Problems found, fixed voluntarilyDrug Quality Assurance—
Feb 22, 2019Problems found, fixed voluntarilyDrug Quality Assurance—
Sep 29, 2011Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: analysis; api manufacture.